Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-28

Clinical Trial Update: Denosumab for Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 1/2 study of denosumab for Type 1 Diabetes, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: RECRUITING